Drug recall · April 10, 2019
Pantoprazole Sodium Delayed-Release Tablets recall
Why: Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.
- Lots / codes
Lot #: PA217060A, Exp 05/2020
- Quantity
- 12,960 bottles
- Company
- Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
- Distribution
- Nationwide in the USA.
- Initiated
- March 29, 2019 · Voluntary: Firm initiated
- Classified
- April 1, 2019
- Reported
- April 10, 2019
- Ended
- September 20, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pantoprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.